Market revenue in 2024 | USD 24.3 million |
Market revenue in 2030 | USD 51.8 million |
Growth rate | 13.5% (CAGR from 2025 to 2030) |
Largest segment | Exocrine |
Fastest growing segment | Endocrine |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Exocrine, Endocrine |
Key market players worldwide | Accuray Inc, AstraZeneca PLC ADR, Novartis AG ADR, Pfizer Inc., F. Hoffmann-La Roche Ltd., Bristol-Myers Squibb Company, Ipsen Pharma, Eli Lilly and Co, Siemens Healthineers AG ADR, Elekta AB ADR |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to pancreatic cancer treatment market will help companies and investors design strategic landscapes.
Exocrine was the largest segment with a revenue share of 88.48% in 2024. Horizon Databook has segmented the Denmark pancreatic cancer treatment market based on exocrine, endocrine covering the revenue growth of each sub-segment from 2018 to 2030.
The pancreatic cancer treatment market in Denmark is experiencing steady growth, driven by rising cancer incidences and an aging population. The centralization of pancreatic surgeries over recent years has played a significant role in improving outcomes.
With nearly 80% of surgeries now conducted in just two high-volume centers. In addition, the average length of hospital stays following pancreatic surgery has reduced from 22 days to 12 days, reflecting improvements in surgical techniques and postoperative care.
Denmark continues to evolve with promising growth, bolstered by the country’s advanced healthcare system and a growing focus on oncology. According to WHO, Denmark records over 1,000 new pancreatic cancer cases annually, with approximately 800 deaths, making it one of the leading causes of cancer-related mortality.
Horizon Databook provides a detailed overview of country-level data and insights on the Denmark pancreatic cancer treatment market , including forecasts for subscribers. This country databook contains high-level insights into Denmark pancreatic cancer treatment market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account